![Nicholes Billinton](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Nicholes Billinton is the founder of Gentronix Ltd.
He received undergraduate and doctorate degrees from the University of Manchester Institute of Science & Technology.
Postes actifs de Nicholes Billinton
Sociétés | Poste | Début |
---|---|---|
Gentronix Ltd.
![]() Gentronix Ltd. BiotechnologyHealth Technology Gentronix Ltd. provides services and solutions to help organizations optimize the development of drugs and other chemicals. It provides contract services for genotoxicity using a patented human cell GADD45a reporter GreenScreen HC and BlueScreen HC assays and related assays including Micronucleus and Ames MPF. The company was founded by Richard Maurice Walmsley in July 1999 and is headquartered in Macclesfield, the United Kingdom. | Fondateur | - |
Formation de Nicholes Billinton
University of Manchester Institute of Science & Technology | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Gentronix Ltd.
![]() Gentronix Ltd. BiotechnologyHealth Technology Gentronix Ltd. provides services and solutions to help organizations optimize the development of drugs and other chemicals. It provides contract services for genotoxicity using a patented human cell GADD45a reporter GreenScreen HC and BlueScreen HC assays and related assays including Micronucleus and Ames MPF. The company was founded by Richard Maurice Walmsley in July 1999 and is headquartered in Macclesfield, the United Kingdom. | Health Technology |